It is estimated that 25% of patients with chronic kidney disease (CKD) also have a diagnosis of diabetes, which has led to a increase in mortality rate of 160% in the last five years.
The coexistence of both diseases also causes high hospitalization rates; This is because it is in advanced stages when patients experience symptoms and complications.
“Therefore, within the framework of World Diabetes Day, it is important to generate a call for attention to the population to have an early diagnosis and thus determine if a patient will develop the disease and what would be the best treatment to prevent complications. Raising awareness is much more than measuring glucose, however, you can live with controlled diabetes, always under continuous medical supervision and taking actions that change lives, “said Dr. Esteban Coto, AstraZeneca’s medical director for Central America and the Caribbean.
This November 14, the World Health Organization and the International Diabetes Federation promote a radical and significant change for more than 460 million people living with diabetes in the world.
Both organizations make a call for action to citizens, considering that many patients do not have access to the different tools or treatments available to address the disease, and additionally seek to motivate diabetics to actively participate in the development of public policies related to the disease. condition.
It’s known that three out of four people with diabetes live in low- or middle-income countries, which makes the care and allocation of resources more challenging to ensure the early diagnosis of the disease, and to ensure that those who live with the disease can have at their disposal medical care, innovative treatments, technology, support and all the care necessary. These are patients who require urgent care and continuous monitoring to cope with their disease, avoiding future complications.
Diabetes which is the common factor in 42% of patients with chronic diseases, is a pathology that appears when the pancreas does not produce enough insulin or when the body does not use it properly. Insulin is a hormone that is responsible for regulating glucose in the body (glycemia). Diabetes is frequently related to hypertension or chronic kidney disease (CKD), increasing the risk of complications in patients.
CKD affects more than 697 million people in the world and it is estimated that in the last 30 years the number of cases increased by 29% due to the aging of the world population, according to the Global Burden of Disease study that quantified the contribution of 354 diseases and 84 risk factors to the presence and mortality of this disease in 195 countries.
“Early diagnosis is necessary to approach the patient from a comprehensive perspective. For this reason, as part of this support for initiatives that facilitate access to medical care, we have developed SEARCH, an initiative that seeks to create awareness in the population about the relevance of prevention and early identification of risk factors, while makes laboratory tests available free of charge to the general public, “said Dr. Coto.
SEARCH is a program developed by AstraZeneca to collaborate in the early detection of CKD in high-risk patients, offering access to laboratory tests to people with risk factors for chronic kidney disease, including patients with diabetes.